NO20051089L - Bredspektrede 2-amino-benzotiazol-sulfonamid-HIV-proteaseinhibitorer - Google Patents

Bredspektrede 2-amino-benzotiazol-sulfonamid-HIV-proteaseinhibitorer

Info

Publication number
NO20051089L
NO20051089L NO20051089A NO20051089A NO20051089L NO 20051089 L NO20051089 L NO 20051089L NO 20051089 A NO20051089 A NO 20051089A NO 20051089 A NO20051089 A NO 20051089A NO 20051089 L NO20051089 L NO 20051089L
Authority
NO
Norway
Prior art keywords
alkyl
amino
hiv protease
benzothiazole
spectrum
Prior art date
Application number
NO20051089A
Other languages
English (en)
Inventor
Piet Tom Bert Paul Wigerinck
Daniel P Getman
Dominique Louis Nest Surleraux
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of NO20051089L publication Critical patent/NO20051089L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Det er beskrevet anvendelsen av 2-aminobenzotiazoler som har formelen (I) hvor R1 er heksahydrofuro[2,3-b]furanyl, tetrahydrofuranyl, oksazolyl, tiazolyl, pyridinyl eller fenyl eventuelt substituert med en eller flere substituenter uavhengig valgt fra C1-6alkyl, hydroksy, amino, halogen, aminoC1-4 alkyl og mono- eller di(C1-4)amino; R2 er hydrogen eller C1-6alkyl, L er en enkeltbinding, -O-, C1-6a1kandiyl -O- eller -O-C1-6a1kandiyl; R3 er fenylC1-4alkyl; R4 er Cl-6 alkyl; R5 er hydrogen eller Cl-6 alkyl; R6 er hydrogen eller Cl-6 alkyl; ved fremstilling av et medikament som er anvendelig for å inhibere mutant HIV-protease i et pattedyr som er infisert med nevnte mutante HIV-protease. Det er også beskrevet nye forbindelser av formel (I).
NO20051089A 2002-08-02 2005-03-01 Bredspektrede 2-amino-benzotiazol-sulfonamid-HIV-proteaseinhibitorer NO20051089L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02078231 2002-08-02
US42786202P 2002-11-20 2002-11-20
PCT/EP2003/050359 WO2004014371A1 (en) 2002-08-02 2003-08-04 Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors

Publications (1)

Publication Number Publication Date
NO20051089L true NO20051089L (no) 2005-05-02

Family

ID=31716850

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051089A NO20051089L (no) 2002-08-02 2005-03-01 Bredspektrede 2-amino-benzotiazol-sulfonamid-HIV-proteaseinhibitorer

Country Status (16)

Country Link
US (2) US20050267156A1 (no)
EP (1) EP1545518A1 (no)
KR (1) KR20050025647A (no)
CN (1) CN1671380B (no)
AP (1) AP1878A (no)
AU (1) AU2003262561B2 (no)
BR (1) BR0305717A (no)
CA (1) CA2492832C (no)
EA (1) EA008594B1 (no)
HR (1) HRP20050605A2 (no)
IL (1) IL166257A (no)
MX (1) MXPA05001275A (no)
NO (1) NO20051089L (no)
NZ (1) NZ538488A (no)
PL (1) PL374948A1 (no)
WO (1) WO2004014371A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005244121B2 (en) * 2004-05-07 2012-01-19 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
JO2841B1 (en) * 2006-06-23 2014-09-15 تيبوتيك فارماسيوتيكالز ليمتد 2-(substituted-amino) -benzothiazole sulfonamide as protease inhibitors HIV (HIV)
US8267163B2 (en) * 2008-03-17 2012-09-18 Visteon Global Technologies, Inc. Radiator tube dimple pattern
WO2011061590A1 (en) 2009-11-17 2011-05-26 Hetero Research Foundation Novel carboxamide derivatives as hiv inhibitors
CN103209963A (zh) 2010-07-02 2013-07-17 吉里德科学公司 作为hiv抗病毒化合物的2-喹啉基-乙酸衍生物
KR20130135826A (ko) 2010-07-02 2013-12-11 길리애드 사이언시즈, 인코포레이티드 Ａｉｄｓ를 치료하기 위한 나프트-2-일아세트산 유도체
US9024038B2 (en) 2010-12-27 2015-05-05 Purdue Research Foundation Compunds and methods for treating HIV
WO2012145728A1 (en) 2011-04-21 2012-10-26 Gilead Sciences, Inc. Benzothiazole compounds and their pharmaceutical use
WO2013103738A1 (en) 2012-01-04 2013-07-11 Gilead Sciences, Inc. Napthalene acetic acid derivatives against hiv infection
US9376392B2 (en) 2012-01-04 2016-06-28 Gilead Sciences, Inc. 2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS
CA2850881C (en) 2012-04-20 2021-02-16 Gilead Sciences, Inc. Benzothiazol-6-yl acetic acid derivatives and their use for treating an hiv infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968942A (en) * 1992-08-25 1999-10-19 G. D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
EP0715618B1 (en) * 1993-08-24 1998-12-16 G.D. Searle & Co. Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
WO1999067254A2 (en) * 1998-06-23 1999-12-29 The United States Of America Represented By The Secretary, Department Of Health And Human Services Multi-drug resistant retroviral protease inhibitors and use thereof
EE05385B1 (et) * 2001-02-14 2011-02-15 Tibotec�Pharmaceuticals�Ltd. LaiaspektrilisedÁ2-(asendatudÁamino)bensotiasoolsulfoonamiididÁkuiÁHIVÁproteaasiÁinhibiitorid,ÁnendeÁvalmistamismeetodÁjaÁkasutamineÁningÁfarmatseutilineÁkompositsioon

Also Published As

Publication number Publication date
CA2492832C (en) 2012-05-22
CN1671380B (zh) 2010-05-26
MXPA05001275A (es) 2005-04-28
EP1545518A1 (en) 2005-06-29
HRP20050605A2 (en) 2006-02-28
IL166257A (en) 2013-04-30
IL166257A0 (en) 2006-01-15
KR20050025647A (ko) 2005-03-14
AP2005003242A0 (en) 2005-03-31
PL374948A1 (en) 2005-11-14
WO2004014371A1 (en) 2004-02-19
BR0305717A (pt) 2004-09-28
CN1671380A (zh) 2005-09-21
CA2492832A1 (en) 2004-02-19
EA008594B1 (ru) 2007-06-29
US20050267156A1 (en) 2005-12-01
AU2003262561A1 (en) 2004-02-25
AP1878A (en) 2008-08-13
NZ538488A (en) 2007-10-26
US20090203742A1 (en) 2009-08-13
EA200500298A1 (ru) 2005-08-25
AU2003262561B2 (en) 2008-10-16

Similar Documents

Publication Publication Date Title
NO20051089L (no) Bredspektrede 2-amino-benzotiazol-sulfonamid-HIV-proteaseinhibitorer
NO20051600L (no) 1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer
NO20082629L (no) Macrocyklisk factor VIIa-inhibitorer anvendbare som antikoagulanter
NO20051965L (no) Nye piperidinderivater for anvendelse ved behandling av kemokinmedierte sykdomstilstander.
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
DK1263722T3 (da) Farmaceutiske sammensætninger, som indeholder azetidinderivat, nye azetidinderivater og fremstilling deraf
DE60230266D1 (de) Phenylpyridincarbonyl piperazinderivate
DK1763534T3 (da) Nye 2-substituerede D-homo-estra-1,3,5(10)-triener som inhibitorer af 17beta-hydroxysteroiddehydrogenasen type 1
NO20081074L (no) Macrocyclisk inhibitorer av hepatitis C-virus
NO20063647L (no) Nye inhibitorer av chymase
HRP20070430T3 (en) (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
NO20062370L (no) Amidderivater
DK1585739T3 (da) Substituerede arylcyclopropylacetamider som glucokinaseaktivatorer
NO20092279L (no) Makrocyklisk factor VIIa inhibitorer anvendbare som antikoagulanter
NO20054135L (no) Kipolinon/benzoksazin derivater og anvendelser derav
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
NO20071008L (no) Fremgangsmate for fremstilling av N-piperidino-1,5-difenylpyrazol-3-karboksamidderivater
NO20062491L (no) Benzoksazinderivter og deres anvendelse
AR045959A1 (es) Derivados de pirazolo- e imidazo-pirimidina
NO20065902L (no) 3-{4-(pyridin-3-yl)fenyl}-5-(1H-,1,2,3-triazol-1-ylmetyl)-1,3-oksazolidin-2-oner som antibakterielle midler
NO20060079L (no) 6-(1,1-Difluoralkyl)-4-Aminopikolinater og deres anvendelse som Herbicider
NO20063111L (no) Fremgangsmate for fremstilling av tiazolpyrimidiner
WO2008146919A1 (ja) リンコサミド誘導体及びこれを有効成分とする抗菌剤
NO20071319L (no) Fremgangsmate for fremstilling av isotiazolderivater.
NO20082226L (no) 6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application